37 patent attorneys
Patent filing for Airbus, CooperVision, Enersys, Exxon Mobil, Materialise, Nike, Ocado, Safran Seats, Sony (all public knowledge).
London, Bath, Cardiff
38 patent attorneys
Patent filing for CO2 Sustain, BioRad, Bivictrix, Cancer Research UK, Clasado Biosciences, Cresendo Biologics, FeTu, Jemmtec, JT International, Samsung Electronics, Smith & Nephew, PPG Industries, Owlstone Medical, Oxa Autonomy, Viasat, various UK and US universities regarding biotech patents (some public knowledge).
Cambridge, Halifax, Leeds, Manchester
69 patent attorneys
EPO oppositions: Abbott against Dexcom over glucose-monitoring devices (including UPC; settled in 2024); European Oppositions Limited against Wyeth/Pfizer over method for production of a polypeptide; straw man oppositions over CRISPR/Cas patent. Litigation: Molecular Instruments against Advanced Cell Diagnostics at UPC over RNA-sequencing technology. Patent filing for Boeing, Capital One, FEI Company, Jeol, Sumitomo Electric Industries, Tepeo, Thermo Fisher, Vodafone. Filing and oppositions for Abbott, Dow Global Technologies, Johnson Matthey (some public knowledge).
London, Cambridge, Reading
95 patent attorneys
EPO oppositions: Johnson & Johnson regarding biological product Stelara for treating autoimmune disease; Novartis against Alexion over patent for antibody eculizumab to prevent transplant rejection; Novartis regarding heart-failure drug Entresto; Sanofi against Amgen over cholesterol-lowering drug Praluent; Sanofi against Moderna and CureVac over mRNA patent; Gilead over HIV blockbuster Descovy; Janssen-Cilag against Amgen regarding blood cancer drug Tecvayli; CSL/uniQure against Pfizer over haemophilia gene therapy Hemgenix. Patent filing and oppositions for Amgen, Barclays Bank, Biogen, Bristol-Myers Squibb, Ethicon, Gilead, GH Research, Micron, Novartis, Regeneron, Takeda, various Johnson & Johnson subsidiaries.
London
19 patent attorneys
EPO oppositions: straw man opposition against Novo Nordisk over type 2 diabetes drug Rybelsus; Akebia against Fibrogen and Sandoz over an HIF-prolyl hydroxylase inhibitor Vafseo for treating chronic kidney disease; Sanofi against Regeneron over Intelliselect transgenic platform. Patent filing for Imagination Technologies, Kymab, Laing O'Rourke, Microsoft, Xilio Therapeutics. Filing and oppositions for Akebia Therapeutics, BP Technologies, Foundation Medicine, Nestlé Sanofi.
London
78 patent attorneys
EPO oppositions: Jotun against competitors over coating technology; Autostore over warehouse robots (ended 2024). Litigation: Advanced Bionics in EPO opposition and UPC case over cochlear implants; Carrier Corp. in EPO opposition and UPC case over cold chain monitoring; Stanley Black & Decker in UPC case over tools. Patent filing for Arm, B/E Aerospace, FujiFilm, Otis Elevator, Pratt & Whitney, Rockwell. Filing and oppositions: BAT/Nicoventures, Borealis, Carrier Corporation, CocaCola, JCB, Nordic Semiconductors, RTX, Waters Corporation (some public knowledge).
London, Birmingham, Bristol, Manchester, Oxford
68 patent attorneys
EPO oppositions: Novo Nordisk regarding diabetes and weight-loss drugs Wegovy, Ozempic and Rybelsus; Teva against Bristol-Myers Squibb over SPC for anticoagulant apixaban/Eliquis; Teva against Novartis regarding multiple sclerosis drug fingolimod/Gilyena and chronic heart-failure drug sacubitril-valsartan/Entresto. Patent filing for Alexion, Amazon, BioMarin, IFF International Flavors & Fragrances, InterDigital, RAI Strategic Holdings, Toyota. Filing and oppositions for BAT/Nicoventures, Boehringer Ingelheim Animal Health, Hoffmann-La Roche, Nestlé, Sony, Teva, Takeda (some public knowledge).
London, Southampton
48 patent attorneys
EPO oppositions: Moderna against CureVac regarding mRNA patent (public knowledge). Patent filing and oppositions for Airbus and Hewlett-Packard. Filing for Nokia, Oxford Nanopore Technologies, Rakuten, Siemens Healthineer, ServiceNow, Sonos, Visa (some public knowledge).
London, Bath, Cardiff, Leeds
27 patent attorneys
EPO oppositions: straw man opposition against CRISPR/Cas patent owned by the University of California. Patent filing for Corning, Deka Products, Imagination Technologies, Norton Limited, Samsung Electronics. Filing and oppositions for Coca Cola, Dow Chemical, Fujifilm, Nestlé, Novartis, Procter & Gamble, Teva, Viatris.
London, Sevenoaks
40 patent attorneys
EPO oppositions: Viatris against Novartis regarding multiple sclerosis drug fingolimod (also regarding infringement action). Patent filing for Huawei, Oracle, Quantum Motion Technologies, St. Jude Medical, Sony, Xerox, V-Nova. Filing and oppositions for Abbott, De La Rue, JT International, Procter & Gamble, Rockwool (some public knowledge).
London
50 patent attorneys
EPO oppositions: The Broad Institute regarding CRISPR/Cas patents and CRISPR gene-editing therapeutic Casgevy; Aselsan against John Cockerill Defence over missile-guidance system; frequently for Mars. Litigation: Arm against ICPillar in UPC action over semiconductors (settled 2024). Patent filing for Acer, Astex Therapeutics, Ericsson, Fujitsu, Hand Held Products, Honeywell, MediTech, Suzuki, ThermoKing (some public knowledge).
Bristol, Glasgow, London, Leeds
108 patent attorneys
EPO oppositions: Philip Morris over heat-not-burn technology; straw man claim against Universities of California and Vienna over CRISPR/Cas patents. Litigation: Amarox/Hetero Lab against Bayer over anticoagulant Xarelto. Patent filing for Fujifilm, Illinois Tool Works, Intel, Philip Morris, Samsung Electronics, Syngenta, W. L. Gore (all public knowledge).
Aberdeen, Alderly Park, Belfast, Birmingham, Edinburgh, Glasgow, Leeds, London, Manchester, Newcastle, Nottingham, Oxford, Sheffield, York.
89 patent attorneys
EPO oppositions: Bristol-Myers Squibb over cancer antibody Opfivo; GSK over RSV vaccine Arexvy; DSM gainst IFF over lactic acid bacteria. Litigation: Healios/Osaka University against Astellas in UPC and national revocation case over method of production of retinal pigment epithelial cell (settled 2024). Patent filing (mostly including oppositions) for AbbVie, Amazon, Alexion Pharmaceuticals, Bicycle Therapeutics, Brother, DSM, Eli Lilly, GSK, Nippon Steel, Ricoh, Pfizer, Regeneron, Roche Diagnostics, Sanofi, Sony, Toyota, UCB.
London, Cambridge, Oxford
60 patent attorneys
EPO oppositions: Edwards Lifesciences against Meril Life Sciences over heart valves; Merck Sharp & Dohme against CureVac over mRNA patents; straw man claim against Novartis over asthma drug omalizumab. Patent filing for Amgen, Boeing, Cisco, Edwards Lifesciences, Elekta, GE Precision Healthcare, Google, Honeywell, Immunocore, LG Display, Sage Therapeutics, Salesforce (some public knowledge).
London
119 patent attorneys
EPO oppositions: Meril Life Sciences regarding heart valves; AB InBex regarding brewing technologies and beer ingredients; the Broad Institute regarding CRISPR/Cas patents. Patent filing and oppositions for AB InBev, Bridgestone, the Broad Institute, Daiichi Sankyo, Gilead, Google, Hewlett Packard, Landis + Gyr, Meril Life Sciences, Menarini, Ricoh, Samsung, Tate & Lyle, Toshiba (some public knowledge).
London, Aberdeen, Birmingham, Cambridge, Edinburgh, Glasgow, Manchester, Oxford
72 patent attorneys
EPO oppositions: Abbott against Dexcom over glucose-monitoring devices. Litigation: Newron Pharmaceuticals against Comptroller General regarding coverage of marketing authorisation for Parkinson’s drug Xadago. Patent filing and oppositions for Abbott, AbbVie, BP, Cisco, Cook Medical, Genzyme, Kenwood, NEC, Novartis. Filing for 3M, Bristol-Myers Squibb (all public knowledge).
London, Birmingham, Cambridge, Manchester, Newcastle, Oxford
100 patent attorneys
Patent filing for 10x Genomics, Bristol-Myers Squibb, Danisco, Genentech, Hithium Tech HK, Hitachi, Hoffmann-La Roche, Imperial Tobacco, Roku, Shin-Etsu Chemical, University of California (all public knowledge).
London, Bristol, Cambridge, Manchester
25 patent attorneys
Patent filing for Atieva, nChain Licensing, Imagination Technologies, Microsoft, Nokia (all public knowledge).
London, Leeds,
11 patent attorneys
Patent filing for Boa Technology, Cybin, Immaterial, MGI Tech, Norton, Procter & Gamble, Small Pharma, Vecor IP Holdings (all public knowledge).
London
47 patent attorneys
EPO oppositions: Novo Nordisk over diabetes drug semaglutide; Astellas against Healios/Osaka University over stem cell technology; Novozymes regarding food technology; Bunge Loders Croklaan regarding oils and fats for food; straw man against the Broad Institute over CRISPR/Cas patent. Patent filing and oppositions for Astellas, Baxter Healthcare, BOE Technology Group, Chevron Phillips Chemical, Here Technologies, Ineos, Novo Nordisk, Novozymes, Sanofi, Unilever.
London, Nottingham
56 patent attorneys
Patent filing for Baxter Medical Systems, Corning Research & Development, Deere & Company, Dish Technologies, Fering, Philip Morris, Qualcomm, Tencent. Patent filing and litigation for Zentiva (all public knowledge).
London, Cambridge
12 patent attorneys
EPO oppositions: Intellia Therapeutics over CRISPR/Cas patents; Glenmark against Amgen over patent for multiple sclerosis drug cinacalcet/Tefidera; ONK Therapeutics regarding patents in relation to cell therapies; Maravai LifeSciences regarding patents related to primers and methods for synthesing 5’-capped RNAs. Patent filing for Advanced Materials, AbbVie, Astex Therapeutics, EsoBiotech, Intellia Therapeutics, Nanofilm, ONK Therapeutics, Polar Doors, Rolls Royce, various US universities (some public knowledge).
Littlehampton
2 patent attorneys
Patent filing and oppositions for Acerus Pharmaceuticals, Apple, Axovia Therapeutics, Celanese, Danaher Corporation, KCI, uniQure, Samsung Bioepis, Toyota.
London
97 patent attorneys
EPO oppositions: Nicroventures over tobacco products; Oppo against Panasonic over mobile communications standards; Playtech over online software patents (both including UPC case); frequently for Procter & Gamble and Takeda. Patent filing for Airbus Defence and Space, Dentsply Sirona, Chevron Phillips Chemical, Google, Mitel Networks, Nokia, Palantir Technologies, Halliburton Energy Services, Hoffmann-La Roche, Indian Oil Corporation, Regeneron, Samsung, Zimmer Biomet. Filing and oppositions for Biogen, British American Tobacco/Nicoventures, Oppo, Sanofi, Takeda (some public knowledge).
Cambridge, Guildford, London, Manchester, Oxford, Tunbridge Wells
57 patent attorneys
Patent filing for Accenture Global Solutions, Apple, Analog Devices, ArvinMeritor Technology, Halliburton Energy, Harvard University, Honeywell, J.C. Bamford Excavators (all public knowledge).
London, Bristol, Sheffield, Warwick
6 patent attorneys
Patent filing for Apollo Intelligent Connectivity, ATS Automation Tooling, Baidu, Husco Automotive, Nutramay Laboratories, STS Technologies.
Cardiff, Cheltenham, London, Malvern, Telford
This ranking depicts the most important UK patent firms according to their reputation in the eight most important fields of technology in patent filing. It includes information on their most significant clients, offices and team size. Clients have been sourced from either the law firm or the EPO register. Practice strength refers to only UK and European patent attorneys working on patent filing and oppositions. The selection of law firms reflects the research of the editorial staff at JUVE Patent and is based on interviews with clients, lawyers and academics worldwide. It remains a subjective view and implies no disparagement of any firm not mentioned here but which is nevertheless active in these fields. The firms are alphabetically listed. To find out more about our rankings and research criteria please click here and here.
We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience. If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission. We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience. Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement. You can find more information about the use of your data in our privacy policy. You can revoke or adjust your selection at any time under Settings.
If you are under 16 and wish to give consent to optional services, you must ask your legal guardians for permission. We use cookies and other technologies on our website. Some of them are essential, while others help us to improve this website and your experience. Personal data may be processed (e.g. IP addresses), for example for personalized ads and content or ad and content measurement. You can find more information about the use of your data in our privacy policy. Here you will find an overview of all cookies used. You can give your consent to whole categories or display further information and select certain cookies.